The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Cagrilintide + Semaglutide Weight Loss Peptides FactorPeptides Dihexa PRAMAH THE HAVEN Growth factors and their peptide mimetics for treatment of traumatic brain injury ScienceDirect The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity Diabetes Therapy Springer Nature Link